1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,370 | 3,210 | 22:27 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIOMAXIMA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 78,60 | -1,26 % | Opening Bell: BioNTech, Hewlett Packard Enterprise, NIO, Oracle, Adobe | Die US-Börsen haben am Montag im Handelsverlauf ins Plus gedreht. Der Dow Jones schloss 0,50 Prozent höher, nachdem er zunächst schwächer gestartet war. Der Nasdaq Composite legte sogar 1,38 Prozent... ► Artikel lesen | |
| 4SC | 0,100 | -23,37 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.12.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 16.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.12.2025ISIN NameDE000A3E5C40 4SC... ► Artikel lesen | |
| SAREPTA THERAPEUTICS | 14,200 | -1,25 % | Sarepta tests new Elevidys safeguards; Sana advances diabetes cell therapy | ||
| VIDAC PHARMA | 0,704 | -1,68 % | Finanzielle Unterstützung durch Hauptaktionäre und Board-Mitglieder der Vidac Pharma Holding PLC | London, GB, 11. März 2026 / IRW-Press / Die Vidac Pharma Holdings Plc. (XETRA: T9G | ISIN:
GB00BM9XQ619 | WKN: A3DTUQ) gibt bekannt, dass bestimmte Aktionäre und Board-Mitglieder der Gesellschaft... ► Artikel lesen | |
| CYTODYN | 0,240 | +9,09 % | CytoDyn Inc.: December 2025 Letter to Shareholders | VANCOUVER, Washington, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your... ► Artikel lesen | |
| ALDEYRA | 3,738 | +0,27 % | Aldeyra Therapeutics, Inc.: Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London | Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced... ► Artikel lesen | |
| NOVOCURE | 10,805 | +2,27 % | NovoCure's Optune Lua Secures Japan Health Ministry's Reimbursement Approval For NSCLC Patients | WASHINGTON (dpa-AFX) - NovoCure Limited (NVCR), Monday announced that Japan's Ministry of Health, Labour and Welfare approved reimbursement for Optune Lua, authorized for use in adult patients... ► Artikel lesen | |
| SENSEI BIOTHERAPEUTICS | 30,210 | -5,30 % | Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed | WASHINGTON (dpa-AFX) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments.Sensei... ► Artikel lesen | |
| TERNS PHARMACEUTICALS | 40,400 | -1,46 % | Terns Pharmaceuticals, Inc.: Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | FOSTER CITY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage oncology company, today announced the closing of its... ► Artikel lesen | |
| REMEGEN CO LTD | 10,300 | +3,52 % | RemeGen Co., Ltd: 2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China | In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements... ► Artikel lesen | |
| ABIONYX PHARMA | 3,285 | 0,00 % | ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital | Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX):
Market:... ► Artikel lesen | |
| MARAVAI LIFESCIENCES | 2,680 | +1,52 % | MARAVAI LIFESCIENCES HOLDINGS, INC. - 10-K, Annual Report | ||
| MEIRAGTX | 6,600 | +1,54 % | MeiraGTx Reports Third Quarter 2025 Financial and Operational Results | Entered into broad strategic collaboration with Eli Lilly and Company ("Lilly") in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company's AAV-AIPL1 program for treatment... ► Artikel lesen | |
| ANEBULO PHARMACEUTICALS | 0,420 | -1,41 % | Anebulo Pharmaceuticals, Inc. Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC | AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic... ► Artikel lesen | |
| ANTENGENE | 0,490 | 0,00 % | ANTENGENE-B (06996): NOTICE OF DATE OF BOARD MEETING |
BIOMAXIMA SA gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell +0,43 % bei einem Aktienkurs von 2,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOMAXIMA SA finden Sie auf Wallstreet Online.